• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tofacitinib-induced Hepatitis and Tuberculosis: A Case of Two Rare Adverse Events in a Single Patient.

作者信息

Taori Kamlesh, Kumar Sanjay, Pateriya Mayankbhushan, Tmu Naveen

机构信息

Bhopal Institute of Gastroenterology & Gastrocare Hospital, Bhopal, India.

出版信息

J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102457. doi: 10.1016/j.jceh.2024.102457. Epub 2024 Nov 28.

DOI:10.1016/j.jceh.2024.102457
PMID:39760118
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11699257/
Abstract
摘要

相似文献

1
Tofacitinib-induced Hepatitis and Tuberculosis: A Case of Two Rare Adverse Events in a Single Patient.托法替布诱发的肝炎和肺结核：1例患者出现两种罕见不良事件
J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102457. doi: 10.1016/j.jceh.2024.102457. Epub 2024 Nov 28.
2
Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.生物制剂或托法替布用于生物制剂治疗类风湿关节炎失败的患者：一项系统评价和网状Meta分析
Cochrane Database Syst Rev. 2017 Mar 10;3(3):CD012591. doi: 10.1002/14651858.CD012591.
3
Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).生物制剂或托法替布单药治疗传统抗风湿药物（DMARD）治疗失败的类风湿关节炎患者：一项Cochrane系统评价和网状Meta分析（NMA）
Cochrane Database Syst Rev. 2016 Nov 17;11(11):CD012437. doi: 10.1002/14651858.CD012437.
4
Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.生物制剂或托法替布用于初治类风湿关节炎患者：一项系统评价和网状Meta分析
Cochrane Database Syst Rev. 2017 May 8;5(5):CD012657. doi: 10.1002/14651858.CD012657.
5
A case of vitiligo secondary to discoid lupus erythematosus treated with tofacitinib.1例盘状红斑狼疮继发白癜风患者接受托法替布治疗。
Medicine (Baltimore). 2025 Jun 27;104(26):e43118. doi: 10.1097/MD.0000000000043118.
6
Tofacitinib Versus Biologic Treatments in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors: Results From a Network Meta-analysis.托法替布与生物制剂治疗对肿瘤坏死因子抑制剂反应不足的活动性类风湿关节炎患者的疗效比较：网状Meta分析结果
Clin Ther. 2016 Dec;38(12):2628-2641.e5. doi: 10.1016/j.clinthera.2016.11.004. Epub 2016 Nov 24.
7
Exploring the Factors Associated With the Discontinuation of Tofacitinib in Patients With Rheumatoid Arthritis: A Retrospective Cohort Study.探索类风湿关节炎患者停用托法替布的相关因素：一项回顾性队列研究。
Int J Rheum Dis. 2025 Jul;28(7):e70356. doi: 10.1111/1756-185x.70356.
8
Comparative of the Effectiveness and Safety of Biological Agents, Tofacitinib, and Fecal Microbiota Transplantation in Ulcerative Colitis: Systematic Review and Network Meta-Analysis.比较生物制剂、托法替尼和粪菌移植治疗溃疡性结肠炎的有效性和安全性：系统评价和网络荟萃分析。
Immunol Invest. 2021 May;50(4):323-337. doi: 10.1080/08820139.2020.1714650. Epub 2020 Feb 2.
9
Ultrasound Evaluation of Therapeutic Response to Tofacitinib and Upadacitinib in Patients with Rheumatoid Arthritis-Real-Life Clinical Data.托法替布和乌帕替尼治疗类风湿关节炎患者疗效的超声评估——真实临床数据
Biomedicines. 2025 May 30;13(6):1339. doi: 10.3390/biomedicines13061339.
10
Comparative efficacy and safety of tofacitinib, with or without methotrexate, in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.托法替布（无论是否联用甲氨蝶呤）用于活动性类风湿关节炎患者的疗效和安全性比较：一项关于随机对照试验的贝叶斯网络荟萃分析
Rheumatol Int. 2015 Dec;35(12):1965-74. doi: 10.1007/s00296-015-3291-4. Epub 2015 May 21.

本文引用的文献

1
Tofacitinib use in ulcerative colitis: An expert consensus for day-to-day clinical practice.托法替布在溃疡性结肠炎中的应用：日常临床实践专家共识
Indian J Gastroenterol. 2024 Feb;43(1):22-35. doi: 10.1007/s12664-023-01507-9. Epub 2024 Feb 12.
2
Drug-induced liver injury due to tofacitinib: a case report.托法替尼致药物性肝损伤 1 例报告。
J Med Case Rep. 2023 Mar 18;17(1):97. doi: 10.1186/s13256-023-03821-4.
3
Risk of Tuberculosis Development in Patients with Rheumatoid Arthritis Receiving Targeted Therapy: a Prospective Single Center Cohort Study.类风湿关节炎患者接受靶向治疗后发生结核病的风险：一项前瞻性单中心队列研究。
J Korean Med Sci. 2021 Mar 15;36(10):e70. doi: 10.3346/jkms.2021.36.e70.
4
Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience.托法替布治疗溃疡性结肠炎：从临床试验到真实世界经验的疗效与安全性
Therap Adv Gastroenterol. 2019 May 16;12:1756284819848631. doi: 10.1177/1756284819848631. eCollection 2019.